We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKR icon
176
Baker Hughes
BKR
$60.1B
$23.6M 0.11%
654,045
+20,204
+3% +$710K
DY icon
177
Dycom Industries
DY
$12.7B
$23.6M 0.11%
119,832
-1,593
-1% -$287K
CTSH icon
178
Cognizant
CTSH
$22.3B
$23.5M 0.11%
304,869
+8,680
+3% +$647K
GIS icon
179
General Mills
GIS
$19.5B
$23.5M 0.11%
318,324
-3,129
-1% -$217K
EEM icon
180
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$23.5M 0.11%
512,065
-131
-0% -$5.65K
CARG icon
181
CarGurus
CARG
$3.15B
$23.4M 0.11%
780,007
-9,305
-1% -$251K
SBUX icon
182
Starbucks
SBUX
$118B
$23.1M 0.11%
237,138
-10,202
-4% -$875K
CSX icon
183
CSX Corp
CSX
$96B
$22.8M 0.11%
659,880
+1,222
+0.2% +$41.5K
CME icon
184
CME Group
CME
$92.3B
$22.6M 0.11%
102,513
-9,555
-9% -$1.98M
VVV icon
185
Valvoline
VVV
$5.05B
$22.6M 0.11%
538,959
-8,004
-1% -$340K
SMMD icon
186
iShares Russell 2500 ETF
SMMD
$3.57B
$22.4M 0.11%
331,389
+100,503
+44% +$6.56M
TPH
187
DELISTED
Tri Pointe Homes
TPH
$22.4M 0.11%
493,489
-6,891
-1% -$295K
SWKS icon
188
Skyworks Solutions
SWKS
$9.54B
$22.1M 0.11%
223,314
-20,126
-8% -$2.13M
CHD icon
189
Church & Dwight Co
CHD
$23.4B
$22M 0.11%
210,228
-1,835
-0.9% -$188K
IJH icon
190
iShares Core S&P Mid-Cap ETF
IJH
$123B
$21.9M 0.1%
351,577
-8,531
-2% -$514K
VRRM icon
191
Verra Mobility
VRRM
$636M
$21.8M 0.1%
783,240
-4,513
-0.6% -$127K
CVLT icon
192
Commault Systems
CVLT
$6.19B
$21.6M 0.1%
140,354
-86,949
-38% -$12.2M
SF
193
Stifel
SF
$12.5B
$21.5M 0.1%
343,781
-5,196
-1% -$296K
SPSC icon
194
SPS Commerce
SPSC
$2.41B
$21.5M 0.1%
110,585
-2,739
-2% -$538K
EPD icon
195
Enterprise Products Partners
EPD
$82.5B
$21.4M 0.1%
735,233
+64,968
+10% +$1.9M
PSX icon
196
Phillips 66
PSX
$83.3B
$21.2M 0.1%
161,551
-111
-0.1% -$15K
LEN icon
197
Lennar Class A
LEN
$20.5B
$21M 0.1%
115,724
-3,304
-3% -$554K
AKAM icon
198
Akamai
AKAM
$16.4B
$20.9M 0.1%
206,764
+8,559
+4% +$834K
ALL icon
199
Allstate
ALL
$67.3B
$20.6M 0.1%
108,869
+5,911
+6% +$1.05M
VIRT icon
200
Virtu Financial
VIRT
$5.12B
$20.6M 0.1%
674,672
-9,844
-1% -$281K

Similar funds

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.